304 related articles for article (PubMed ID: 25417810)
1. Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome.
Anderson CL; Kuzmicki CE; Childs RR; Hintz CJ; Delisle BP; January CT
Nat Commun; 2014 Nov; 5():5535. PubMed ID: 25417810
[TBL] [Abstract][Full Text] [Related]
2. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum.
Smith JL; Reloj AR; Nataraj PS; Bartos DC; Schroder EA; Moss AJ; Ohno S; Horie M; Anderson CL; January CT; Delisle BP
Am J Physiol Cell Physiol; 2013 Nov; 305(9):C919-30. PubMed ID: 23864605
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of loss of Kv11.1 K+ current in mutant T421M-Kv11.1-expressing rat ventricular myocytes: interaction of trafficking and gating.
Balijepalli SY; Lim E; Concannon SP; Chew CL; Holzem KE; Tester DJ; Ackerman MJ; Delisle BP; Balijepalli RC; January CT
Circulation; 2012 Dec; 126(24):2809-18. PubMed ID: 23136156
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor.
McBride CM; Smith AM; Smith JL; Reloj AR; Velasco EJ; Powell J; Elayi CS; Bartos DC; Burgess DE; Delisle BP
J Membr Biol; 2013 May; 246(5):355-64. PubMed ID: 23546015
[TBL] [Abstract][Full Text] [Related]
6. Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
Mihic A; Chauhan VS; Gao X; Oudit GY; Tsushima RG
PLoS One; 2011 Mar; 6(3):e18273. PubMed ID: 21483829
[TBL] [Abstract][Full Text] [Related]
7. The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote.
Hedley PL; Kanters JK; Dembic M; Jespersen T; Skibsbye L; Aidt FH; Eschen O; Graff C; Behr ER; Schlamowitz S; Corfield V; McKenna WJ; Christiansen M
Circ Cardiovasc Genet; 2013 Oct; 6(5):452-61. PubMed ID: 24021552
[TBL] [Abstract][Full Text] [Related]
8. Rescue of protein expression defects may not be enough to abolish the pro-arrhythmic phenotype of long QT type 2 mutations.
Perry MD; Ng CA; Phan K; David E; Steer K; Hunter MJ; Mann SA; Imtiaz M; Hill AP; Ke Y; Vandenberg JI
J Physiol; 2016 Jul; 594(14):4031-49. PubMed ID: 26958806
[TBL] [Abstract][Full Text] [Related]
9. HERG-F463L potassium channels linked to long QT syndrome reduce I(Kr) current by a trafficking-deficient mechanism.
Yang HT; Sun CF; Cui CC; Xue XL; Zhang AF; Li HB; Wang DQ; Shu J
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):822-7. PubMed ID: 19215240
[TBL] [Abstract][Full Text] [Related]
10. Identification of the cyclic-nucleotide-binding domain as a conserved determinant of ion-channel cell-surface localization.
Akhavan A; Atanasiu R; Noguchi T; Han W; Holder N; Shrier A
J Cell Sci; 2005 Jul; 118(Pt 13):2803-12. PubMed ID: 15961404
[TBL] [Abstract][Full Text] [Related]
11. Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
Thomas D; Wimmer AB; Karle CA; Licka M; Alter M; Khalil M; Ulmer HE; Kathöfer S; Kiehn J; Katus HA; Schoels W; Koenen M; Zehelein J
Cardiovasc Res; 2005 Aug; 67(3):487-97. PubMed ID: 15950200
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of the human ether-a-go-go-related gene Q738X mutant associated with hereditary long QT syndrome type 2.
Han SN; Yang SH; Zhang Y; Sun XY; Duan YY; Hu XJ; Fan TL; Huang CZ; Yang G; Zhang Z; Zhang L
Int J Mol Med; 2014 Sep; 34(3):810-5. PubMed ID: 24993425
[TBL] [Abstract][Full Text] [Related]
13. Novel mutation in the Per-Arnt-Sim domain of KCNH2 causes a malignant form of long-QT syndrome.
Rossenbacker T; Mubagwa K; Jongbloed RJ; Vereecke J; Devriendt K; Gewillig M; Carmeliet E; Collen D; Heidbüchel H; Carmeliet P
Circulation; 2005 Mar; 111(8):961-8. PubMed ID: 15699249
[TBL] [Abstract][Full Text] [Related]
14. Mouse ERG K(+) channel clones reveal differences in protein trafficking and function.
Lin EC; Moungey BM; Lim E; Concannon SP; Anderson CL; Kyle JW; Makielski JC; Balijepalli SY; January CT
J Am Heart Assoc; 2014 Dec; 3(6):e001491. PubMed ID: 25497881
[TBL] [Abstract][Full Text] [Related]
15. Novel intracellular transport-refractory mutations in KCNH2 identified in patients with symptomatic long QT syndrome.
Fukumoto D; Ding WG; Wada Y; Fujii Y; Ichikawa M; Takayama K; Fukuyama M; Kato K; Itoh H; Makiyama T; Omatsu-Kanbe M; Matsuura H; Horie M; Ohno S
J Cardiol; 2018 Apr; 71(4):401-408. PubMed ID: 29146210
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation in human ether-a-go-go-related gene, alanine to proline at position 490, found in a large family with autosomal dominant long QT syndrome.
Pellegrino PL; Bafunno V; Ieva R; Brunetti ND; Mavilio G; Sessa F; Grimaldi M; Margaglione M; Di Biase M
Am J Cardiol; 2007 Jun; 99(12):1737-40. PubMed ID: 17560885
[TBL] [Abstract][Full Text] [Related]
17. Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome.
Ficker E; Dennis AT; Obejero-Paz CA; Castaldo P; Taglialatela M; Brown AM
J Mol Cell Cardiol; 2000 Dec; 32(12):2327-37. PubMed ID: 11113008
[TBL] [Abstract][Full Text] [Related]
18. Defective assembly and trafficking of mutant HERG channels with C-terminal truncations in long QT syndrome.
Gong Q; Keeney DR; Robinson JC; Zhou Z
J Mol Cell Cardiol; 2004 Dec; 37(6):1225-33. PubMed ID: 15572053
[TBL] [Abstract][Full Text] [Related]
19. High-throughput phenotyping of heteromeric human ether-à-go-go-related gene potassium channel variants can discriminate pathogenic from rare benign variants.
Ng CA; Perry MD; Liang W; Smith NJ; Foo B; Shrier A; Lukacs GL; Hill AP; Vandenberg JI
Heart Rhythm; 2020 Mar; 17(3):492-500. PubMed ID: 31557540
[TBL] [Abstract][Full Text] [Related]
20. C-terminal β9-strand of the cyclic nucleotide-binding homology domain stabilizes activated states of Kv11.1 channels.
Ng CA; Ke Y; Perry MD; Tan PS; Hill AP; Vandenberg JI
PLoS One; 2013; 8(10):e77032. PubMed ID: 24204727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
